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AbstrACt 
Introduction Endotracheal intubation and invasive 
mechanical ventilation are lifesaving interventions that 
are commonly performed in the intensive care unit 
(ICU). Laryngeal oedema is a known complication of 
intubation that may cause airway obstruction in a patient 
on extubation. To date, the only test available to predict 
this complication is the cuff leak test (CLT); however, 
its diagnostic accuracy and utility remains uncertain. 
Herein, we report the protocol for the CuffLeak and 
AirwayObstruction in MechanicallyVentilated ICU Patients 
(COMIC) pilottrial.
Methods and analysis This will be a multicentred, 
pragmatic, pilot randomised controlled trial (RCT). We will 
enrol 100 mechanically ventilated patients in the ICU who 
are deemed ready for extubation. We will exclude patients 
at a high risk of laryngeal oedema. All enrolled patients 
will have a CLT done before extubation. In the intervention 
arm, the results of the CLT will be communicated to the 
bedside physician, and decision to extubate will be left to 
the treating team. In the control arm, respiratory therapist 
will not communicate the results of the CLT to the treating 
physician, and the patient will be extubated regardless 
of the CLT result. Randomisation will be done in a 1:1 
allocation ratio, stratified by size of the endotracheal tube 
and duration of invasive mechanical ventilation. Although 
we will examine all clinical outcomes relevant for the 
future COMIC RCT, the primary outcomes of the COMIC 
pilottrial will be feasibility outcomes including: consent 
rate, recruitment rate and protocol adherence. Clinical 
outcomes include postextubation stridor, reintubation, 
emergency surgical airway, ICU mortality, in hospital 
mortality, duration of mechanical ventilation and ICU length 
of stay in days.
Ethics and dissemination The Hamilton Integrated 
Research Ethics Board, Imam Abdulrahman Bin Faisal 
University Institutional Review Board and Bioethical 
Commission of the Jagiellonian University approved this 
study. The trial results will be disseminated via publication 
in peer-reviewed journals.
trial registration number NCT03372707.
IntroduCtIon
Endotracheal intubation and invasive 
mechanical ventilation are lifesaving inter-
ventions; however, it can be associated with 
serious complications. Laryngeal oedema 
(LO) occurs in 4%–55% of patients postex-
tubation.1–5 LO is caused by marked polymor-
phonuclear infiltration to the traumatised 
upper airway postintubation.6 The incidence 
of LO increases as the duration of intubation 
accrues, but it can occur as early as the first 
24 hours of intubation.5 LO can cause airway 
narrowing and increased airflow velocity, 
if the narrowing exceeds 50% of the lumen 
diameter, leading to stridor and respiratory 
distress postextubation.7 As a result, 3.5% 
(range 0%–10.5%) of patients with LO will 
fail extubation and subsequently require rein-
tubation.5 The morbidity and mortality associ-
ated with reintubation are well described.8–13 
Identifying patients with LO can be chal-
lenging. The presence of the endotracheal 
strengths and limitations of this study
 ► This is the first pilot randomised trial to assess fea-
sibility and impact of performing the cuff leak test 
(CLT) before extubation in mechanically ventilated 
patients at average risk of laryngeal oedema.
 ► Information from this study will facilitate the conduct 
of a larger trial powered to determine the impact of 
the CLT on patient-important outcomes.
 ► The multicentred, international design will support 
external validity and implementation of the results
 ► As the most accurate way to define a failed or 
passed CLT is unknown (ie, quantitatively vs qual-
itatively), we are defining a failed CLT as inability to 
auscultate air movement around the endotracheal 
tube with the cuff deflated.
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tube (ETT) prevents direct visualisation of the upper 
airway before extubation; therefore, clinicians cannot 
accurately predict airway obstruction before it occurs. A 
cuff leak test (CLT) was first described in 1988 as a surro-
gate and a screening test for airway oedema before extu-
bation.14 This test involves deflating the balloon cuff on 
an ETT and observing if the patient can breathe around 
it. If air can pass around the ETT, it suggests that the 
airway is patent.14 A small leak or complete absence of 
one would suggest an airway obstruction or narrowing.
There are conflicting results on the clinical utility and 
diagnostic accuracy of a CLT. Two meta-analyses of obser-
vational studies examined the diagnostic accuracy of a 
CLT.5 15 One reports that a failed CLT is not sensitive but 
is specific for predicting risk of LO and reintubation.15 
The second meta-analysis found that a failed CLT was 
associated with LO, particularly in patients with >5 days’ 
duration of intubation; however, the odds of reintuba-
tionwas not increased.5
Despite the lack of high-quality studies, an absent cuff 
leak usually results in delayed extubation and exposure 
to medications aimed at treating airway oedema. A recent 
meta-analysis of 11 randomised controlled trials (RCTs) 
enrolling 2472 patients found that systemic corticoste-
roids reduces the risk of postextubation airway events 
(relative risk (RR) 0.43, 95% CI 0.29 to 0.66, p=0.002).16 
A subgroup analysis showed that the high-risk subgroup 
benefited the most (RR 0.34, 95% CI 0.24 to 0.48, 
p=0.99). Empirical use of corticosteroids for all patients is 
not justified (RR 0.62, 95% CI 0.24 to 1.61, p<0.001). A 
false positive CLT can unnecessarily delay extubation, 
increasing intensive care unit (ICU) stay and associated 
risks of invasive mechanical ventilation. However, if a 
CLT is not performed, or if in case of a false negative test, 
some patients may fail the extubation exposing them to 
the morbidity associated with reintubation.
Recent clinical practice guidelines reflect this uncer-
tainty. The American Thoracic Society guidelines on 
liberation of mechanical ventilation issued a weak recom-
mendation (very low quality evidence) for performing 
CLT in mechanically ventilated adults who are at high risk 
for postextubation stridor (such as airway trauma) and 
those with a potential for increased risk of LO (eg, intu-
bated for 7 days or more).17 Given this persistent uncer-
tainty, we believe a properly powered RCT is necessary to 
investigate the clinical utility of the CLT and its impact 
on patient outcomes. Our aim is to report the protocol 
for the CuffLeak and AirwayObstruction in Mechanically-
Ventilated ICU Patients (COMIC) pilottrial to determine 
the feasibility of undertaking a large RCT addressing 
this research question. Given the clinical equipoise, we 
hypothesise that this will be a feasible trial, and the results 
will inform the larger COMIC RCT.
MEthodsAndAnAlysIs
We registered this trial in  ClinicalTrials. gov.
design
The COMIC pilot trial will be a multicentre, randomised, 
concealed, parallel-group, pragmatic pilot trial. Three 
centres from North America, Europe and the Middle East 
will participate in the COMIC pilot trial. These academic 
tertiary care ICUs are located in Hamilton, Canada; 
Krakow, Poland; and Dammam, Saudi Arabia.
Population
Eligible patients will be mechanically ventilated adults 
(>18 years) in the ICU, and an order to extubate has been 
provided by the treating physician. We list the exclusion 
criteria in table 1.
Eligible non-randomised patients
We will record all patients who were eligible but not 
randomised for any of the following reasons: (1) thepa-
tient or substitute decision maker (SDM) declined 
consent; (2) there are no family members or SDM for 
the patient; (3) the ICU physician declined enrolling the 
patient; and (4) any other reason.
Table 1 Exclusion criteria
Exclusion criteria Definitions
1. Palliative care 
plan or plan of care 
does not include 
reintubation




Current pregnancy or up to and 
including 7 days postpartum.
3. High risk patient 
for LO
Burn patients, smoke inhalation 
injuries, blunt or penetrating trauma of 
the neck and airway, recent head and 
neck surgeries, self-extubation event 
and patients admitted with airway 
oedema.25–27
4. Difficult or 
traumatic intubation
Direct laryngoscopy Cormack-Lehane 
Grade 4 (regardless of the number of 
intubation attempts); three or more 
attempts at intubation regardless of 
the grade; an intubating supraglottic 
device, Bougie or bronchoscopy 
required previously to intubate; or 





Vocal cord paralysis, tracheolaryngeal 
neoplasm, tracehomalasia, 
tracheolaryngeal stenosis or previous 
head and neck surgeries.
6. Mechanical ventilation via a tracheostomy
7. Patients who failed extubation attempt within the current 
ICU admission.
8. History of postextubation airway obstruction.
9. The ICU physician declined enrolling the patient.
10. Patient had a failed CLT in the previous 24 hours. 
CLT, cuff leak test; ICU, intensive care unit; LO, laryngeal oedema.
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randomisation and allocation concealment
The study researchcoordinator (RC) will use the REDCap 
randomisation module to randomise eligible patients in 
a 1:1 allocation using undisclosed variable block sizes.18 
We will stratify randomisation by: (A) ETT size into two 
strata (external diameter equivalent to that of <8 mm 
and ≥8 mm ETTs), (B) duration of mechanical ventila-
tion before randomisation into two strata (>7 days and ≤7 
days) and (C) by study site.
Intervention
A dedicated unblinded study respiratorytherapist (RT) or 
a trained researchpersonnel (referred to as an RT from 
here on) will perform the CLT on all enrolled patients. 
The patients will first be switched to volume assist-control 
(V-AC) with a set respiratory rate of 10 breaths/minute 
(to allow patient assist), a constant flow of 60 L/min 
and tidal volume set to match the average tidal volume 
currently being delivered during supportive ventilation. 
The RT will document one representative inhaled tidal 
volume and three exhaled volumes after switching to 
V-AC mode. The cuff of the ETT will then be deflated with 
a 10 mL syringe. Once the patient has accommodated 
to the deflated cuff, we will record the inspiratory and 
expiratory volumes of three consecutive breaths. The cuff 
leak test is performed by: (A) auscultation with a stetho-
scope to identify audible air leak around the ETT, (B) 
determining the difference between the average exhaled 
volume prior to cuff deflation and the average exhaled 
volume after cuff deflation, (C) measure the difference 
between the average inhaled and exhaled volumes after 
cuff deflation and (D) calculate the percent change in 





Expiratory tidal voluumeballon inflated−Expiratory tidal volumeballoon deflated
Expiratory tidal volumeballoon inflated ) 
 
We define a ‘failed CLT’ as the RT being unable to 
identify air leak during auscultation. Patients randomised 
to the intervention arm will have the results of the CLT 
(whether failed or passed) communicated to the treating 
physician; the treating physician will decide whether to 
proceed with extubation based on the CLT results. It is at 
the discretion of the treating physician to provide corti-
costeroids at any dose or frequency and/or delay extuba-
tion by 24 hours should the patient fail the CLT.19 Those 
randomised to the control arm will not have the results 
of the CLT (whether failed or passed) communicated to 
the treating team and will be extubated regardless of the 
results (figure 1).
blinding
Although the intervention arm of the study is unblinded 
(ie, results of CLT is known), patients, physicians, RCs, 
study investigators, adjudicators and data analysts will not 
be aware of the results of CLT in the control group. The 
unblinded RT will document the CLT results on the CLT 
paper case report form (CRF). The RT will enter the CLT 
results data into the electronic CRF (eCRF) in the trial 
database on REDCap. The eCRF for the CLT will only be 
accessible and visible to the RT. For both the interven-
tion and control arms, the paper CRF will be stored in the 
patient binder. For patients randomised to the control 
arm, the RT will seal the paper CRF in an envelope before 
storing in the patient binder. In case of emergency, and if 
knowing the results of the CLT will change the manage-
ment of the patient (eg, administering corticosteroids to 
a patient who developed respiratory failure after learning 
the result of a failed CLT), the treating physician will have 
the ability to request the CLT results for a control arm 
patient. In such an event, the sealed paper CRF can be 
opened to reveal the CLT results to the treating physician 
and patient care team, and the methods centre must be 
notified of this protocol violation.
Patients and public involvement
Patients and the public were not involved in the design or 
the conduct of this study. Once the study is published, we 
plan to involve patient representatives in the Data Safety 
Monitoring Board in the larger COMIC Trial.
outCoMEs
Feasibility outcomes
Although we will report all clinical outcomes relevant 
for the future COMIC RCT, the primary outcomes of the 
COMIC pilottrial will be feasibility, including:
Consent rate
We define a successful consent rate as 70% of SDMs or 
patients approached to consent, choosing to take part in 
the trial. We will calculate this as the overall proportion 
of SDMs or patients consenting out of those approached 
(with 95% CI). As this is a pilottrial, the steeringcommittee 
will review the consent rate weekly, and if applicable, 
Figure 1 Flow chart demonstrating the two groups that a 
patient may be randomised into and course of action for each 
group depending on if the patient fails or passes their cuff 
leak test. CLT, cuff leak test; RT, respiratory therapist.
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discuss barriers to informed consent and use factors asso-
ciated with improved consent rate.20
Recruitment rate
We define a successful recruitment rate as achieving 
enrolment of 100 patients, conventionally expressed as 
four patients per centre per month over the duration of 
the trial. While the pilot trial is ongoing, steeringcom-
mittee will review recruitment weekly and the screening 
records monthly. If applicable, we will address barriers 
to enrolment to maximise recruitment. The recruitment 
metric will be measured and interpreted at the end of the 
pilot trial by calculating the mean number of recruited 
patients per active screening month.
Protocol adherence
We define a successful adherence as ≥80%. We will calcu-
late the adherence as the proportion of patients that were 
assigned to the control arm being extubated immedi-
ately after the CLT. As this pilot trial is ongoing, we will 
review adherence monthly and investigate the reasons 
for compliance failure. We will investigate all reasons for 
failure to extubate immediately after randomisation in 
the control arm and report them as a protocol violation. 
The RC will review the RT’s charting and the medication 
profile to determine actual compliance. RC will record all 
reasons for non-compliance for both groups using distin-
guishing clinical reasons (eg, palliation, death, consent 
withdrawal and errors).
Clinical outcomes
The clinical outcomes are:
(1) Postextubation stridor: defined as an audible high-
pitched inspiratory noise caused by turbulent airflow 
through the narrowed airway that is detectable with or 
without a stethoscope within 48 hours of extubation; (2) 
clinically significant postextubation stridor: defined as 
stridor (see definition above) that requires medical inter-
vention such as the administration of systemic steroids, 
racemic epinephrine, Heli-ox or reintubation; (3) reintu-
bation: defined as reintubation within 72 hours of original 
extubation while in the ICU. Reasons for reintubation 
will be recorded; (4) emergency surgical airway: defined 
as performing urgent tracheostomy or cricothyrotomy for 
a life-threatening airway obstruction; (5) in ICU mortality 
truncated at 30 days; (6) in-hospital mortality truncated at 
30 days; (7) duration of mechanical ventilation: defined 
as time on the ventilator after randomisation in days; and 
(8) ICU length of stay in days.
data collection and follow-up
The RC will screen all patients in the ICU during week-
days to avoid incurring additional weekend on-call costs. 
RC will collect information including the patient baseline 
data (eg, demographics, illness severity, advanced life 
support including duration of mechanical ventilation, 
daily data (eg, CLT results, postextubation stridor, rate 
of reintubation and steroids administered) and source 
documentation that will help with the adjudication of 
outcomes. The RC will review patient’s charts daily for up 
to 72 hours postextubation for the trial data including: 
stridor, reintubation and emergency surgical airway. 
Once patients are discharged from the ICU, they will no 
longer be followed daily, but we will record the patients’ 
vital status at 30 days if the patient was not discharged 
from the hospital. Mortality, duration of ventilation and 
ICU stay outcomes will be censored at 30 days.
duration of the CoMIC pilot trial
We began enrolling patients on 5 July 2018. We expect 
that 12 months will be required to recruit 100 patients, 
with a trial end date of approximately June 2019. We will 
need a subsequent 3 months to validate the data, adjudi-
cate the outcomes, analyse, interpret and present results. 
The total duration of the pilottrial may take up to 15 
months to complete.
sample size and justification
We plan to enrol 100 patients for the pilot trial to ensure 
feasibility criteria will be appropriately examined.21 22
Analysis of the CoMIC pilot trial
The analysis and reporting of this pilot trial will follow 
the Consolidated Standards of Reporting Trials exten-
sion to pilot trials.23 We will use descriptive statistics to 
analyse the baseline characteristics and report them as 
a count (per cent) for categorical variables, and mean 
(SD) or median (first quartile, third quartile) for contin-
uous variables, depending on the distribution. We will 
base the analysis of feasibility outcomes on descriptive 
statistics reported as percentages with 95% CI. Calcula-
tion of consent and recruitment feasibility outcomes for 
the COMIC pilottrial will not require analysis by group; 
however, compliance rates will have to be assessed for 
each group. Therefore, we will analyse clinical outcomes 
as means or proportions in each arm. In addition, given 
the small sample size and short duration, we will not 
conduct any subgroup or interim analyses.
The analysis of clinical outcomes will follow intention-
to-treat approach. These analyses will be exploratory. 
The proportion of patients in the two groups with the 
primary and secondary clinical outcomes will be analysed 
using the Mantel-Haenszelχ2 test of Fisher’s exact test. A 
t-test will be used for continuous outcomes, and a statis-
tical significance will be set at alpha=0.05. These analyses 
will be exploratory, and the results will be reported as 
estimates of effect with 95% CIs. We will develop a full 
statistical analysis plan adherent to the intention-to-treat 
principle. All analyses will be performed using SAS V.9.2.
EthICsAnddIssEMInAtIon
Ethics
Centres will follow the consent models outlined below, 
depending on the local ethics approval.
Mixed consent model (a priori and deferred consent)
As most patients will be incapable at the time of enrol-
ment, the SDM will provide consent a priori whenever 
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possible. We will follow the two-phase, 13-step informed 
consent process that we have used in prior international 
trials.20
If we cannot locate the SDM for a priori consent, then 
we will enrol patients using deferred consent until we can 
contact the SDM as permitted by local Research ethics 
board (REBs). The consent encounter will occur as soon 
as possible. If the SDM then declines further trial proceed-
ings data collected will be used up to that point unless the 
SDM requests otherwise. For the patient who has no iden-
tifiable family member, or power of attorney to provide 
consent, we propose to continue study protocols while we 
attempt to locate an SDM and/or the patient recovers. In 
the event that such a patient subsequently recovers to the 
extent thatan informed consent can be provided, we will 
ask the patient for their consent.
Having a mixed consent model is crucial to ensure the 
proper conduct of the COMIC trial. To begin with, extu-
bating patients is a daily routine in the ICU and should 
not be delayed unless there is a valid reason to do so. 
Therefore, having either a waved or deferred consent 
model is necessary to make this study feasible, and we 
have successfully used deferred consent model in a recent 
RCT.24
Moreover, although CLT is routinely performed in 
some institutions before extubation, there is no clear 
evidence that this practice benefit patients.5 The ethical 
principle of clinical equipoise underlies all medical 
research and obligates researchers to provide standard 
treatment unless there is uncertainty about the relative 
effectiveness of the standard and experimental treat-
ments. Recent clinical practice guidelines for using CLT 
reflect this uncertainty.17 In this case, it can be argued the 
relative benefits and risks of the CLT, as compared with 
standard therapy, are unknown, or thought to be equiv-
alent or better.
Waived consent model
Certain participating centres may receive approval (under 
the justification that clinical equipoise exists and the test 
itself is harmless) to waive consent. This is conditional on 
REB approval at those participating centres.
We will keep all personal information in a locked room. 
No personal information is available on REDCap.
dissemination and protocol amendments
We will submit the primary RCT results for publication 
to a peer-reviewed journal. If the protocol needs amend-
ment, investigators are required to inform the institu-
tional REB (as well aspatients) and receive approval.
dIsCussIon
Extubation can be a precarious procedure for patients 
admitted to the ICU. Therefore, critical care physi-
cians undertake the utmost cautions before extubating 
patients. The CLT is the most commonly used test to 
detect LO in mechanically ventilated patients. However, 
the diagnostic accuracy and impact on clinical outcomes 
in average risk patients is unclear. Recent guidelines 
issued a weak recommendation to perform CLT before 
extubating high-risk patients.17 Patients who fail a CLT 
are often treated with high-dose systemic corticosteroids 
and extubation may be delayed; both outcomes are likely 
not desirable by most patients.
To date, no RCT has been done examining this 
important question. Observational studies have showed 
that in a subset of patients a CLT may help identify 
patients at higher risk of airway obstruction. We there-
fore have described the protocol for a pilot RCT to deter-
mine the feasibility of a large trial to examine the utility 
of CLT. Physician and public acceptance of performing 
such a protocol is uncertain, and it is integral we examine 
the recruitment, consent and adherence rates before we 
pursue a large-scale RCT.
In conclusion, this protocol describes the design and 
methodology of the COMIC pilottrial. We believe the 
results will help inform the design and the conduct of 
a large RCT examining the effect of bedside CLT on 
postextubation events in average risk mechanically venti-
lated patients.
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